Description

What is Tesamorelin?

Tesamorelin is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) — the endogenous hypothalamic peptide responsible for stimulating growth hormone secretion from pituitary somatotrophs. It consists of the full 44-amino acid sequence of human GHRH with a trans-3-hexenoic acid group attached at the N-terminus, a modification that significantly improves its stability against enzymatic degradation compared to native GHRH in laboratory conditions.

What distinguishes tesamorelin research peptide 10mg from other GHRH analogs in the peptide research catalog is its clinical research history. Tesamorelin is the only GHRH analog that has progressed through the full pharmaceutical development pipeline — it was FDA-approved in 2010 under the brand name Egrifta for a specific clinical application. That regulatory history means tesamorelin carries a substantially deeper and more rigorously documented research record than most peptide research compounds, with pharmacokinetic data, receptor binding studies, metabolic investigation, and safety profiling published across peer-reviewed literature spanning over two decades. Researchers looking to buy tesamorelin 10mg for laboratory investigation are working with one of the most scientifically characterised GHRH analogs available. Supplied by Atlanta Advanced Peptides for in-vitro and in-vivo scientific research use only — not for human or veterinary use.

Tesamorelin 10mg Compound Specifications

Tesamorelin vs Other GHRH Analogs — Understanding the Differences

Researchers comparing tesamorelin with other GHRH receptor agonists in the catalog — particularly the CJC-1295 in our CJC-1295/Ipamorelin blend — will notice both operate through the same GHRH receptor system but have meaningfully different research profiles and structural characteristics worth understanding before selecting one for a protocol.

CJC-1295 without DAC is a shorter modified GHRH fragment (amino acids 1-29 with modifications) designed primarily for pulsatile GH stimulation research. Tesamorelin uses the complete 44-amino acid GHRH sequence with a stability-enhancing N-terminal modification — a full-length analog rather than a truncated fragment. In laboratory models, this structural difference influences the depth and duration of GHRH receptor engagement. Tesamorelin also has a more thoroughly characterised pharmacokinetic profile than most research peptides because of its clinical development history, which gives researchers access to published data that simply does not exist for many other GHRH analogs.

Tesamorelin in Scientific Research

The published research record on tesamorelin growth hormone research is more extensive than virtually any other compound in this catalog outside of BPC-157. The combination of academic investigation and pharmaceutical development research has produced a literature base that covers GHRH receptor biology, GH axis pharmacology, metabolic effects, cardiovascular biology, and cognitive research — each documented in controlled laboratory and clinical research settings.

GHRH Receptor Biology and Growth Hormone Secretion

The foundational research on tesamorelin research peptide 10mg involves its interaction with the GHRH receptor (GHRHR) on pituitary somatotroph cells. Published studies have characterised tesamorelin’s binding affinity at GHRHR, its downstream activation of adenylyl cyclase and cAMP signalling, and the resulting GH pulse patterns in controlled laboratory research models. Because tesamorelin uses the full 44-amino acid GHRH sequence, its receptor engagement profile has been studied as a closer analog to endogenous GHRH than shorter fragment analogs — making it a relevant research tool for laboratories investigating native GHRH receptor biology rather than truncated analog pharmacology.

Visceral Adipose Tissue and Lipid Metabolism Research

The largest body of published tesamorelin research outside of pure receptor biology involves visceral adipose tissue and lipid metabolism. This area of investigation grew directly from tesamorelin’s clinical development pipeline — published studies have examined how sustained GHRH receptor stimulation influences visceral fat mobilisation, lipid oxidation signalling, and adipose tissue biology in controlled research environments. The metabolic research literature on tesamorelin is more detailed and rigorously documented than for most peptide research compounds precisely because of the clinical investigation that surrounded its development. Researchers working in adipose tissue biology and lipid metabolism research will find tesamorelin’s published record in this domain unusually comprehensive.

Cardiovascular Biology Research

Published studies have examined tesamorelin growth hormone research in cardiovascular biology contexts, with laboratory and clinical investigations documenting its interaction with endothelial function models, lipid profile regulation, and inflammatory marker pathways in controlled research settings. The cardiovascular research literature on tesamorelin expanded significantly during its pharmaceutical development period and continues to be referenced in published work examining the relationship between GH axis biology and cardiovascular health markers in research models.

Cognitive Biology and Neurological Research Models

A growing and increasingly published area of tesamorelin research involves cognitive biology. Laboratory and clinical research studies have examined how GHRH receptor stimulation influences IGF-1 levels in the CNS, with published investigations exploring tesamorelin’s interaction with hippocampal biology, cognitive function markers, and neuroprotective pathway models in controlled research environments. This area of investigation connects buy tesamorelin 10mg research directly to the broader literature on GH axis interactions with brain biology — a research domain that has attracted significant scientific attention and continued publication in recent years.

IGF-1 Signalling and Anabolic Biology Research

Growth hormone’s primary anabolic signalling pathway runs through IGF-1 production — predominantly hepatic but also locally in muscle and other tissues. Published laboratory studies have examined how tesamorelin-induced GH secretion influences systemic and local IGF-1 levels in research models, with downstream investigation into protein synthesis signalling, muscle biology, and anabolic pathway regulation in controlled experimental environments. This area of the tesamorelin research literature connects GHRH receptor pharmacology directly to skeletal muscle and body composition biology research.

Research Disclaimer: All research references above relate exclusively to published scientific literature and controlled laboratory investigations. Tesamorelin 10mg supplied by Atlanta Advanced Peptides is for research use only and is not approved for human or veterinary application outside of its FDA-approved clinical indication, and is supplied here strictly for laboratory research purposes.

Why 10mg for Tesamorelin Research

Tesamorelin has a relatively high molecular weight at 5135.9 g/mol compared to many other peptide research compounds. This means that on a molar basis, 10mg of tesamorelin represents fewer moles of compound than 10mg of a lower-molecular-weight peptide. For laboratory protocols requiring sufficient compound for multiple experimental sessions, extended study designs, or parallel research arms, the 10mg format is the practical choice. Researchers who have worked with tesamorelin in published studies will already know that adequate compound supply is an important consideration in protocol planning for this particular peptide.

Ordering Tesamorelin 10mg

To buy tesamorelin 10mg from Atlanta Advanced Peptides, add the compound to your cart and complete checkout through our secure encrypted payment gateway. Orders are processed Monday through Friday during standard business hours. All orders ship via USPS Ground Advantage or USPS Priority Mail with full tracking provided by email.

All purchases are made with the explicit understanding that:

• The purchaser is 18 years of age or older
• The compound will be used solely for legitimate in-vitro or in-vivo laboratory research
• The product will not be used for human or veterinary purposes under any circumstances

Reconstitution Guidelines for Research Use

Tesamorelin 10mg is supplied as a lyophilized powder and requires reconstitution before use in laboratory protocols. It is compatible with bacteriostatic water as the reconstitution solvent. Given tesamorelin’s higher molecular weight, calculate your target concentration carefully before adding solvent. Inject solvent slowly down the inner wall of the vial without shaking vigorously, store reconstituted compound refrigerated at 2–8°C, and apply standard laboratory PPE and sterile technique throughout.

Related Research Compounds

Researchers working with Tesamorelin frequently reference these related compounds in their laboratory studies:

• CJC-1295 / Ipamorelin Blend — the most widely referenced dual-pathway GH secretagogue blend, offering a different GHRH analog research profile alongside Ipamorelin for comparative GH axis research
• Ipamorelin 10mg — selective GHRP analog operating through GHS-R1a rather than GHRHR, frequently studied in parallel with GHRH analogs in GH axis research models
• GLP-1 SM 10mg — GLP-1 receptor agonist studied in overlapping metabolic and adipose tissue biology research contexts alongside tesamorelin
• MOTS-c 10mg — mitochondrial-derived peptide referenced in metabolic regulation and body composition research models alongside GH axis compounds
• Bacteriostatic Water 10ml — recommended reconstitution solvent for laboratory use

Research Disclaimer

⚠️ For Laboratory Research Use Only

Tesamorelin 10mg supplied by Atlanta Advanced Peptides is intended strictly for in-vitro and in-vivo scientific research conducted by qualified researchers in controlled laboratory environments. This compound is not approved for human consumption or veterinary use outside of its specific FDA-approved clinical indication, and is not supplied here for any clinical or therapeutic application. It is not classified as a supplement, food product, or over-the-counter agent. All purchasers must be 18 years of age or older. By completing a purchase, the buyer explicitly confirms that this compound will be used solely for legitimate scientific research purposes and in full compliance with all applicable local, state, and federal laws and regulations.